Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV000807872 | SCV000947948 | uncertain significance | Severe combined immunodeficiency due to CORO1A deficiency | 2021-09-24 | criteria provided, single submitter | clinical testing | This sequence change replaces serine with leucine at codon 427 of the CORO1A protein (p.Ser427Leu). The serine residue is moderately conserved and there is a large physicochemical difference between serine and leucine. This variant is present in population databases (rs781058961, ExAC 0.008%). This variant has not been reported in the literature in individuals with CORO1A-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site, but this prediction has not been confirmed by published transcriptional studies. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
| Ambry Genetics | RCV003372861 | SCV004064072 | uncertain significance | Inborn genetic diseases | 2023-09-12 | criteria provided, single submitter | clinical testing | The c.1280C>T (p.S427L) alteration is located in exon 10 (coding exon 9) of the CORO1A gene. This alteration results from a C to T substitution at nucleotide position 1280, causing the serine (S) at amino acid position 427 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |